HIT to LEAD to Candidate development of a Transcription Repressor Inhibitory Compound (TRIC), which switches off bacterial resistance to a broad band antibiotic
Key Data
Projectlead
Project team
Dr. Mark Sephton, Patrik Züger
Project partners
BioVersys AG
Project status
completed, 11/2011 - 10/2013
Funding partner
KTI-Projekt
Project budget
1'382'297 CHF
Einsiedlerstrasse 31
8820 Wädenswil